UniCredit Evo will fund early-stage developers of innovative technology and mid-stage investments in more established companies.

Frontier IP's half-yearly report sees its revenues quadruple as the company looks ahead to its first IPO exit within 12 to 18 months.

Fraunhofer spinout Nexwafe will use the capital to commercialise its silicon wafers for solar cells.

The financial services provider will look to invest in seed-stage companies developing disruptive technologies with long development time frames.

The in-video advertising technology producer will use the Unilever-backed round to scale its technology and form new content partnerships.

Evotec has spun out Topas Therapeutics, which is working on treatments for conditions including MS, also contributing to a series A round.

Evotec has spun out Topas Therapeutics, which is working on treatments for conditions including MS, also contributing to a series A round.

The in-video advertising technology producer will use the Unilever-backed round to scale its technology and form new content partnerships.

The financial services provider will look to invest in seed-stage companies developing disruptive technologies with long development time frames.